Weekly Medication Recap 3/2/2026 – New FDA approvals for Dupixent, Hernexeos, Desmoda & more

from Clinical Guideline InSights · host Guideline Central

A weekly medication recap going over new FDA medication approvals and indications for Loargys, Dupixent, Desmoda, Hernexeos, Yuviwell, and Sogroyahttps://www.guidelinecentral.com/drugs/

Episode metadata supplied by the publisher feed · Published Mar 2, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Weekly Medication Recap 3/2/2026 – New FDA approvals for Dupixent, Hernexeos, Desmoda & more

0:00 1:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Clinical Guideline InSights?

This episode is 1 minute long.

When was this Clinical Guideline InSights episode published?

This episode was published on March 2, 2026.

Can I download this Clinical Guideline InSights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!